Skip to main content
. 2013 Sep 19;9:1899–1906. doi: 10.3762/bjoc.9.224

Table 2.

In vitro antibiotic activity (MIC, µg/mL) of tetramic acids.a,b

S1 S26 S4 S2 E1 E2 P1 P9 P9B H3 H4

2ac 4 8 8 8 8 8 16 8 32 16 4
2bc 1 1 1 2 2 4 4 4 d 2 0.5
2cc 8 8 8 8 8 8 16 8 8 4 0.25
2dc 2 2 2 2 2 2 4 1 4 1 0.12
2ec 2 16 16 16 8 0.5 4 1 4 >64 ≤0.1
2f >64 >64 >64 >64 >64 >64 16 8 16 >64 >64
2g 8 8 8 8 16 8 64 16 8 4 0.25
2h 2 2 2 2 2 2 8 4 >64 >64 8

3a >64 >64 32 >64 16 16 8 8 8 >64 >64
3b 4 8 2 8 1 2 0.5 0.5 0.5 8 1
3c 8 32 32 16 8 16 8 8 8 32 4
3d 8 64 32 32 8 16 8 8 4 64 4
3e >64 >64 >64 >64 >64 >64 64 64 64 >64 64
3f >64 >64 >64 >64 >64 >64 >64 >64 >64 >64 >64

1cc 0.1 0.12 1 64 ≤0.1 ≤0.1 2 2 2 >64 0.5
1d 8 64 32 64 32 4 64 64 >64 >64 16
Linec 2 2 2 2 2 2 1 0.5 0.5 16 4
Cip 0.1 0.5 0.12 16 1 32 1 1 1 0.5 ≤0.1
Amox d d d d d d >0.03 8 d d d
Caz 8 16 16 d d d d d d d d

aAbbreviation; S1; S. aureus 1, ATCC13709 in vivo (methicillin sensitive), S26; S. aureus 26, ATCC25923 (vancomycin susceptible), S4; S. aureus 4, Oxford, S2; S. aureus 2, (MRSA in vivo), E1; E. faecalis 1, ATCC29212 VanS (vancomycin susceptible), E2; E. faecium 1, VanA (vancomycin resistant), P1; S. pneumonia 1, ATCC49619 (erythromycin susceptible), P9; S. pneumonia 9, (multi-drug resistant), P9B; S. pneumonia 9 in presence of 2.5% horse blood, H3; H. influenzae 3, ATCC31517 MMSA, H4; H. influenzae 4, LS2 Efflux knock out, Line; linezolid, Cip; ciprofloxacin, Amox; amoxicillin, Caz; ceftazidime. bAll analogues are inactive (MIC > 64 µg/mL) against E. coli 1, ATCC25922 (non pathogenic strain), E. coli 50, Ec49 No efflux and P. aeruginosa 1, ATCC27853. cThe activity was reported in our previous publication [10]. dNot determined.